Adefovir dipivoxil added to ongoing lamivudine in chronic hepatitis B with YMDD mutant hepatitis B virus-Reference-Cited by-同舟云学术

Adefovir dipivoxil added to ongoing lamivudine in chronic hepatitis B with YMDD mutant hepatitis B virus

Published:2004-01 Issue:1 Volume:126 Page:81-90
ISSN:0016-5085
Container-title:Gastroenterology
language:en
Short-container-title:Gastroenterology

Author:

Perrillo Robert,Hann Hie-won,Mutimer David,Willems Bernard,Leung Nancy,Lee William M.,Moorat Alison,Gardner Stephen,Woessner Mary,Bourne Eric,Brosgart Carol L.,Schiff Eugene

Publisher

Elsevier BV

Subject

Gastroenterology,Hepatology

Reference20 articles.

1. Medical progress;Lee;N Engl J Med,1997

2. Long-term follow-up of HBeAg-positive patients treated with interferon alfa for chronic hepatitis B;Niederau;N Engl J Med,1996

3. Lamivudine as initial treatment for chronic hepatitis B in the United States;Dienstag;N Engl J Med,1999

4. Lamivudine and alpha interferon combination treatment of patients with chronic hepatitis B infection;Schalm;Gut,2000

5. Lamivudine treatment reduces progression to cirrhosis in patients with chronic hepatitis B;Goodman;J Hepatol,1999

Cited by 371 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Research Progress in Competitive Purine Antagonists;Current Medicinal Chemistry;2023-10

2. FDA approved five-membered ring fused pyrimidine-based derivatives and their biological properties;Fused Pyrimidine-Based Drug Discovery;2023

3. Adefovir for lamivudine-resistant hepatitis B;Antiviral Therapy;2022-02-28

4. Safety, efficacy, and pharmacokinetics of pradefovir for the treatment of chronic hepatitis B infection;Antiviral Research;2020-02

5. Viral quasispecies of hepatitis B virus in patients with YMDD mutation and lamivudine resistance may not predict the efficacy of lamivudine/adefovir rescue therapy;Experimental and Therapeutic Medicine;2019-02-11